Related Experiment Video
Updated: Sep 27, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Untangling ligand induced activation and desensitization of G-protein-coupled receptors
Peter J Woolf1, Jennifer J Linderman
1Department of Chemical Engineering, University of Michigan, Ann Arbor 48109, USA.
Abstract:
Long-term treatment with a drug to a G-protein-coupled receptor (GPCR) often leads to receptor-mediated desensitization, limiting the therapeutic lifetime of the drug. To better understand how this therapeutic window might be controlled, we created a mechanistic Monte Carlo model of the early steps in GPCR signaling and desensitization. Using this model we found that the rates of G-protein activation and receptor phosphorylation can be partially decoupled by varying the drug-receptor dissociation rate constant, k(off), and the drug's efficacy, alpha. The maximum ratio of G-protein activation to receptor phosphorylation (GARP) was found for drugs with an intermediate k(off) value and small alpha-value. Changes to the cellular environment, such as changes in the diffusivity of membrane molecules and the G-protein inactivation rate constant, affected the GARP value of a drug but did not change the characteristic shape of the GARP curve. These model results are examined in light of experimental data for a number of GPCRs and are found to be in good agreement, lending support to the idea that the desensitization properties of a drug might be tailored to suit a specific application.
Insights
Drug efficacy and receptor desensitization can be controlled by adjusting drug-receptor interactions. This study models G-protein-coupled receptor (GPCR) signaling to optimize drug design for longer therapeutic effects.
Area of Science:
- Pharmacology
- Computational Biology
- Biophysics
Background:
- Long-term drug treatment targeting G-protein-coupled receptors (GPCRs) often results in receptor desensitization, limiting therapeutic efficacy.
- Understanding the mechanisms controlling GPCR desensitization is crucial for developing drugs with extended therapeutic windows.
Purpose of the Study:
- To develop a mechanistic Monte Carlo model simulating early-stage GPCR signaling and desensitization.
- To investigate how drug-specific parameters and cellular environment influence the balance between G-protein activation and receptor phosphorylation.
Main Methods:
- Developed a mechanistic Monte Carlo model for GPCR signaling and desensitization.
- Analyzed the impact of drug-receptor dissociation rate constant (k(off)) and drug efficacy (alpha) on signaling outcomes.
- Assessed the influence of cellular environment factors like molecular diffusivity and G-protein inactivation rate.
Main Results:
- Demonstrated that G-protein activation and receptor phosphorylation rates can be decoupled by modulating k(off) and alpha.
- Identified an optimal drug profile (intermediate k(off), small alpha) for maximizing the ratio of G-protein activation to receptor phosphorylation (GARP).
- Observed that cellular environment changes affect GARP values but not the fundamental shape of the GARP curve.
Conclusions:
- Model predictions align with experimental data for various GPCRs, supporting the model's validity.
- Suggests that drug desensitization properties can be rationally designed by tuning drug-receptor interaction kinetics.
- Offers a framework for tailoring drug properties to achieve desired therapeutic lifetimes for GPCR-targeted therapies.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Related Concept Videos
GPCR Desensitization
Activation and Inactivation of G Proteins
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
Two...
G Protein-coupled Receptors
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...